TIC10 T7001
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.
CAS nr:
1616632-77-9
Purity:
98%
Molecular Weight:
386,49
SMILES:
Cc1ccccc1CN1C2=NCCN2C2=C(CN(Cc3ccccc3)CC2)C1=O
Formula:
C24H26N4O
Pathway:
Apoptosis,Apoptosis
Target:
TNF,Apoptosis
